Ryan Fields named co-leader of Solid Tumor Therapeutics Program


Ryan C. Fields, MD, FACS, associate professor of surgery and surgical oncology at Washington University School of Medicine, has been appointed as co-leader of the Solid Tumor Therapeutics Program (STTP) at Siteman Cancer Center. He joins current program leaders Lee Ratner, MD, PhD, and Joshua Rubin, MD, PhD in overseeing the program. The overall goals of STTP are to apply discoveries in ‘omics and DNA repair research to novel clinical trials for solid malignancies, especially endometrial, gastrointestinal, non-small cell lung, astroglial and prostate cancers.

Researchers in the Solid Tumor Therapeutics Program study solid cancer sites to work towards improved patient care treatment choices for cancer patients. Fields is a surgical oncologist who specializes in pancreatic, liver, bile duct, stomach and intestinal cancers, along with soft tissue sarcoma, melanoma and other skin cancers. He will help oversee these specific cancer sites and lead continued clinical and research advancements.

Fields has a particular interest in treating cancer patients who are at a high risk for recurrence, and in researching and using novel treatment choices to improve patient survival rates. In 2017, he was named to the Best Doctors in America list, which recognizes the top five percent of U.S. physicians, as chosen by fellow physicians. Fields earned his medical degree from Duke University, completed a residency in General Surgery at Barnes-Jewish Hospital, and trained in complex surgical oncology at Memorial Sloan-Kettering Cancer Center.

Latest Posts

Higher doses of radiation don’t improve survival in prostate cancer

CRISPR enhances cancer immunotherapy

NCI director talks immunotherapy, cancer research on Med Campus

View All News